Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D03ZME
|
|||
| Former ID |
DNCL002265
|
|||
| Drug Name |
Darinaparsin
|
|||
| Synonyms |
ZIO-101
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Hematologic tumour [ICD-11: 2B33.Y] | Phase 2 | [1] | |
| Liver cancer [ICD-11: 2C12; ICD-10: C22] | Phase 2 | [1] | ||
| Multiple myeloma [ICD-11: 2A83; ICD-10: C90] | Phase 2 | [1] | ||
| Peripheral T-cell lymphoma [ICD-11: 2A90.C; ICD-10: C84.4; ICD-9: 202.7] | Phase 2 | [2] | ||
| Company |
ZIOPHARM Oncology
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C12H22AsN3O6S
|
|||
| Canonical SMILES |
C[As](C)SCC(C(=O)NCC(=O)O)NC(=O)CCC(C(=O)O)N
|
|||
| InChI |
1S/C12H22AsN3O6S/c1-13(2)23-6-8(11(20)15-5-10(18)19)16-9(17)4-3-7(14)12(21)22/h7-8H,3-6,14H2,1-2H3,(H,15,20)(H,16,17)(H,18,19)(H,21,22)/t7-,8-/m0/s1
|
|||
| InChIKey |
JGDXFQORBMPJGR-YUMQZZPRSA-N
|
|||
| CAS Number |
CAS 69819-86-9
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID | ||||
| ChEBI ID |
CHEBI:94295
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT00421213) Phase II Study of ZIO-101 in Advanced Blood and Bone Marrow Cancers. U.S. National Institutes of Health. | |||
| REF 2 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.